These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16696337)

  • 21. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.
    Schleiss MR; Bernstein DI; McVoy MA; Stroup G; Bravo F; Creasy B; McGregor A; Henninger K; Hallenberger S
    Antiviral Res; 2005 Jan; 65(1):35-43. PubMed ID: 15652969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.
    Yang ZH; Lucia HL; Tolman RL; Colonno RJ; Hsiung GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1563-8. PubMed ID: 2554800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.
    Schleiss MR; Buus R; Choi KY; McGregor A
    Future Virol; 2013 Dec; 8(12):1151-1160. PubMed ID: 24465269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
    Choi KY; El-Hamdi NS; McGregor A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Jinye Baidu Granule on fetal growth and development with maternal active human cytomegalovirus infection.
    Jiang H; Chen SH; Wen LZ
    Chin J Integr Med; 2006 Dec; 12(4):250-4. PubMed ID: 17361519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of vaccination on cytomegalovirus-associated interstitial pneumonia in strain 2 guinea pigs.
    Bia FJ; Lucia HL; Fong CK; Tarsio M; Hsiung GD
    J Infect Dis; 1982 May; 145(5):742-7. PubMed ID: 6281341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection.
    McVoy MA; Wang JB; Dittmer DP; Bierle CJ; Swanson EC; Fernández-Alarcón C; Hernandez-Alvarado N; Zabeli JC; Schleiss MR
    J Virol; 2016 Sep; 90(17):7715-27. PubMed ID: 27307567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.
    Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD
    Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs.
    Bratcher DF; Bourne N; Bravo FJ; Schleiss MR; Slaoui M; Myers MG; Bernstein DI
    J Infect Dis; 1995 Oct; 172(4):944-50. PubMed ID: 7561214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease.
    Adler SP; Nigro G
    Herpes; 2008 Nov; 15(2):24-7. PubMed ID: 19856544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
    Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
    Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
    Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guinea pig and human cytomegaloviruses do not share cross-reactive neutralizing epitopes.
    Adler SP; Shaw KV; McVoy M; Burke RL; Liu H
    J Med Virol; 1995 Sep; 47(1):48-51. PubMed ID: 8551258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes.
    Schleiss MR; Fernández-Alarcón C; Hernandez-Alvarado N; Wang JB; Geballe AP; McVoy MA
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of guinea pig cytomegalovirus and guinea pig herpes-like virus: pathogenesis and persistence in experimentally infected animals.
    Tenser RB; Hsiung GD
    Infect Immun; 1976 Mar; 13(3):934-40. PubMed ID: 178599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.
    Choi KY; El-Hamdi NS; McGregor A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
    Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
    J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.
    Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC
    Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.